Correlation Between Zentalis Pharmaceuticals and Tcr2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Tcr2 Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Tcr2 Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Tcr2 Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zentalis and Tcr2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Tcr2 Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Tcr2 Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Tcr2 Therapeutics. In addition to that, Zentalis Pharmaceuticals is 1.05 times more volatile than Tcr2 Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Tcr2 Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 111.00 in Tcr2 Therapeutics on September 2, 2024 and sell it today you would earn a total of 37.00 from holding Tcr2 Therapeutics or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 23.99% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Tcr2 Therapeutics
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zentalis Pharmaceuticals and Tcr2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Tcr2 Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.| Zentalis Pharmaceuticals vs. Tff Pharmaceuticals | Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Inhibrx | Zentalis Pharmaceuticals vs. Enliven Therapeutics |
| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |